| Literature DB >> 23082221 |
Stephen N White1, Michelle R Mousel, Lynn M Herrmann-Hoesing, James O Reynolds, Kreg A Leymaster, Holly L Neibergs, Gregory S Lewis, Donald P Knowles.
Abstract
BACKGROUND: Like human immunodeficiency virus (HIV), ovine lentivirus (OvLV) is macrophage-tropic and causes lifelong infection. OvLV infects one quarter of U.S. sheep and induces pneumonia and body condition wasting. There is no vaccine to prevent OvLV infection and no cost-effective treatment for infected animals. However, breed differences in prevalence and proviral concentration have indicated a genetic basis for susceptibility to OvLV. A recent study identified TMEM154 variants in OvLV susceptibility. The objective here was to identify additional loci associated with odds and/or control of OvLV infection. METHODOLOGY/PRINCIPALEntities:
Mesh:
Year: 2012 PMID: 23082221 PMCID: PMC3474742 DOI: 10.1371/journal.pone.0047829
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Genomic regions associated with susceptibility to OvLV.
| SNP | Chr | Position (bp) | Animal Set | Best fitting model | NominalP-value | EmpiricalP-value | Odds Ratio | Genes within 100 Kb on either side |
| OAR1_185953850 | 1 | 172,600,491 | All | additive | 3.3×10−8 | 0.006 | 1.98 | DPPA2 |
| OAR1_185953850 | 1 | 172,600,491 | Polypay | additive | 6.5×10−7 | 0.048 | 2.60 | DPPA2 |
| OAR1_186779231 | 1 | 173,437,685 | Polypay | dominant | 1.7×10−7 | 0.012 | 4.45 | − |
| OAR4_38205790 | 4 | 35,398,410 | All | dominant | 3.1×10−6 |
| 2.84 | − |
| s54511 | 6 | 12,045,872 | Polypay | additive | 3.8×10−6 |
| 2.36 | CAMK2D |
| OAR7_82644472 | 7 | 75,607,567 | Polypay | additive | 5.7×10−6 |
| 2.53 | GPHN |
| OAR8_73555614 | 8 | 68,927,958 | All | recessive | 8.7×10−6 |
| 2.61 | UTRN |
| OAR8_88021348 | 8 | 82,158,519 | Rambouillet | recessive | 4.2×10−6 | 0.051 | 4.46 | SYTL3 |
| OAR9_35880400 | 9 | 34,065,208 | Polypay | additive | 2.4×10−6 |
| 2.46 | ST18 |
| OAR17_5388531 | 17 | 4,862,358 | All | additive | 9.2×10−7 | 0.13 | 7.57 | TMEM154 |
| s19031 | 17 | 12,016,817 | All | additive | 6.4×10−6 |
| 1.73 | − |
| OAR18_9395406 | 18 | 9,449,325 | All | genotypic | 2.1×10−6 |
| 2.74 | FUS |
| OAR20_19572554 | 20 | 18,822,181 | All | additive | 2.0×10−6 |
| 1.80 | SUPT3H |
| s56930 | X | 22,443,790 | All | genotypic | 7.2×10−6 |
| 2.43 | − |
: P>0.15
: SNP located within gene
: SNP located within 35 Kb of gene
Genomic regions associated with OvLV serologic status comparing association with and without accounting for TMEM154 mutations.
| SNP | Animal Set | NominalP-value (Without TMEM154) | NominalP-value (Accounting TMEM154) | EmpiricalP-value (Without TMEM154) | EmpiricalP-value (Accounting TMEM154) | Genes within 100 Kb on either side |
| OAR1_185953850 | All | 3.3×10−8 | 5.2×10−6 | 0.006 |
| DPPA2 |
| OAR1_185953850 | Polypay | 6.5×10−7 | 3.8×10−5 | 0.048 |
| DPPA2 |
| OAR1_186779231 | Polypay | 1.7×10−7 | 4.5×10−6 | 0.012 |
| − |
| OAR4_38205790 | All | 3.1×10−6 | 1.0×10−4 |
|
| − |
| s54511 | Polypay | 3.8×10−6 | 6.7×10−4 |
|
| CAMK2D |
| OAR7_82644472 | Polypay | 5.7×10−6 | 3.0×10−5 |
|
| GPHN |
| OAR8_73555614 | All | 8.7×10−6 | 5.8×10−5 |
|
| UTRN |
| OAR8_88021348 | Rambouillet | 4.2×10−6 | 3.2×10−6 | 0.051 | 0.052 | SYTL3 |
| OAR9_35880400 | Polypay | 2.4×10−6 | 1.1×10−5 |
|
| ST18 |
| OAR17_5388531 | All | 9.2×10−7 |
| 0.13 |
| TMEM154 |
| s19031 | All | 6.4×10−6 | 1.0×10−4 |
|
| − |
| OAR18_9395406 | All | 2.1×10−6 | 1.1×10−6 |
|
| FUS |
| OAR20_19572554 | All | 2.0×10−6 | 3.4×10−6 |
|
| SUPT3H |
| s56930 | All | 7.2×10−6 | 8.5×10−5 |
|
| − |
: P>0.15
: SNP located within gene
: SNP located within 35 Kb of gene
Figure 1Manhattan plot for susceptibility to OvLV.
The Manhattan plot shows nominal P-values from association with serological status by chromosomal position. Representative data from the all-breeds, additive mode of inheritance analysis are shown. The top red line shows a genome-wide significance threshold defined by nominal P-values of 1x10-6, which is P = 0.05/50,000. The lower blue line shows a genome-wide suggestive significance threshold defined by 1x10-5.
Genomic regions associated with control of OvLV.
| SNP | Chr | Position (bp) | Animal Set | Best fitting model | Nominal P-value | EmpiricalP-value | Genotypic Log10 Conc. Diff. | Genes within 100 Kb on either side |
| DU231007_156 | 3 | 58,955,947 | Polypay | dominant | 3.5×10−6 |
| 0.78 | PAX8, IGK |
| OAR3_144283427 | 3 | 135,036,950 | Polypay | genotypic | 2.0×10−6 |
| 0.84 | SLC11A2 |
| OAR3_144414855 | 3 | 135,043,018 | Polypay | genotypic | 2.0×10−6 |
| 0.84 | SLC11A2 |
| s27054 | 5 | 6,250,424 | Polypay | recessive | 1.3×10−6 | 0.047 | 0.84 | C19orf42 |
| OAR9_10735564 | 9 | 10,702,461 | Polypay | dominant | 1.6×10−6 | 0.073 | 0.76 | − |
| OAR9_10749779 | 9 | 10,725,321 | Polypay | additive | 1.5×10−6 | 0.069 | 0.92 | − |
| s48118 | 9 | 14,589,931 | Polypay | dominant | 9.4×10−6 |
| 0.62 | BAI1 |
| OAR13_56607666 | 13 | 52,062,577 | All | additive | 4.3×10−6 |
| 0.58 | TGM6 |
| OAR18_5646940 | 18 | 5,926,257 | Polypay | genotypic | 2.5×10−6 |
| 0.68 | MEF2A |
| OAR18_5701234 | 18 | 5,984,107 | Polypay | genotypic | 2.6×10−6 |
| 0.68 | MEF2A |
| s65956 | 20 | 29,213,047 | Rambouillet | dominant | 5.9×10−8 | 0.001 | 0.89 | ZNF192 |
| OAR22_43742889 | 22 | 39,013,937 | Polypay | additive | 9.4×10−6 |
| 1.32 | INPP5F |
| OAR23_40410527 | 23 | 38,376,040 | All | additive | 1.5×10−6 | 0.092 | 0.66 | DLGAP1 |
: P>0.15
: SNP located within gene
: SNP located within 35 Kb of gene
Figure 2Manhattan plot for control of OvLV infection.
The Manhattan plot shows nominal P-values from association with proviral concentration by chromosomal position. Representative data from the Rambouillet, dominant mode of inheritance analysis are shown. The top red line shows a genome-wide significance threshold defined by nominal P-values of 1x10-6, which is P = 0.05/50,000. The lower blue line shows a genome-wide suggestive significance threshold defined by nominal P-values of 1x10-5.